Sentences
Showing 81-100 of 159 items.
| PubMed | Sentence | Cancertype | Gene ID |
|---|---|---|---|
| 16186803 | activated Notch3 can function as an oncogene in the developing brain, and link the Notch pathway to human choroid plexus tumor pathogenesis | brain, | 4854 |
| 33931470 | Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis. | unknown | 29126 |
| 28486549 | p53 tumor suppressor pathway was downregulated as demonstrated by both aCGH and RNA-seq analysis. Notch, EGFR, NRAS, and RB1 pathways were also significantly dysregulated in tumors compared with normal liver tissue | liver, | 7157 |
| 17353266 | Data demonstrate a novel link between p53 and Notch1 in keratinocyte differentiation upon genotoxic stress and suggest a novel tumor suppressor mechanism of p53 in the development of HPV-induced tumors. | None | 7157 |
| 18757425 | data link EWS-FLI1 to the NOTCH and p53 pathways and provide a plausible basis both for NOTCH tumor suppressor effects and oncogenesis of cancers that retain wild-type p53 | None | 7157 |
| 19751190 | Studies indicate that MAML1 functions as a coactivator for the tumor suppressor p53, MEF2C, beta-catenin and Notch signaling. | None | 7157 |
| 23034333 | The pleiotropic nature of miRNA-10b was due to its suppression of multiple tumor suppressors, including TP53, FOXO3, CYLD, PAX6, PTCH1, HOXD10 and NOTCH1. | None | 7157 |
| 26877611 | Report a simple, non-germline murine intrahepatic cholangiocarcinoma model with activated Notch, loss of p53 and IDH1R132C mutation, supporting the oncogenic potential of IDH1R132C. | liver,cholangiocarcinoma, | 3417 |
| 22237151 | study reports presence of loss-of-function mutations and deletions of the EZH2 and SUZ12 genes, which encode components of the Polycomb repressive complex 2 (PRC2), in 25% of T cell acute lymphoblastic leukemias; study suggesst tumor suppressor role for PRC2 in leukemia and suggest a gnized dynamic interplay between oncogenic NOTCH1 and PRC2 | leukemia, | 23512 |
| 22237151 | studies suggest a tumor suppressor role for PRC2 in human leukemia and suggest a hitherto unrecognized dynamic interplay between oncogenic NOTCH1 and PRC2 function | leukemia, | 23512 |
| 21637926 | Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling. | liver, | 864 |
| 19074836 | Notch inhibits expression of the Kr??ppel-like factor 4 tumor suppressor in the intestinal epithelium. | None | 9314 |
| 26400206 | arcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR-200c increased by garcinol treatment was found to target and downregulate Notch1 | None | 406985 |
| 29444743 | Tumor-Suppressive MicroRNA-708 Targets Notch1 to Suppress Cell Proliferation and Invasion in Gastric Cancer | gastric, | 100126333 |
| 19765378 | [The OTT-MAL fusion oncogene: another Notch in megakaryoblastic leukemia]. | leukemia, | 64783 |
| 23040356 | BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients. | leukemia, | 64919 |
| 25574842 | results indicate that NOTCH serves as a tumor suppressor in the bladder and that loss of this pathway promotes mesenchymal and invasive features. | bladder, | 4853 |
| 26769750 | NOTCH2 acts as an oncogene that promotes bladder cancer growth and metastasis through epithelial-to-mesenchymal transition, cell-cycle progression, and maintenance of stemness. Inhibition of NOTCH2 is a rational novel treatment strategy for invasive bladder cancer. | bladder, | 4853 |
| 29643502 | Review of the roles of NOTCH1 and NOTCH2 in urinary bladder cancer suggests that NOTCH1 acts as a tumor suppressor and NOTCH2 acts as an oncogene that promotes cell proliferation and metastasis through epithelial-to-mesenchymal transition, cell cycle progression, and maintenance of stemness. | bladder, | 4853 |
| 28745938 | NEDD4 exerts its oncogenic function partly due to regulation of PTEN and Notch-1 in bladder cancer cells. | bladder, | 4734 |